Monthly Archives: December 2010

Aliskiren Combination patent revoked in India

Aliskiren is, a renin inhibitor, marketed by Novartis. Aliskiren combination is protected by WO2002040007 and its equivalent patent is granted in India  [212199  (724/cHENP/2003)]. The  ‘199 patent is revoked in post grant opposition filed by Sun Pharma Decision is available at … Continue reading

Posted in Patent case | Tagged , , | Leave a comment

CI & Pharma News: 28/12/2010

1) Jazz Pharmaceuticals Announces New Patent Issued for Sodium Oxybate (Press Release). The New patent 7851506 is expires on Dec 22, 2019 and listed in Orange Book. Note: Recently Jazz pharma has sued Roxane for ANDA filing. 2) Cephalon Wants FTC To … Continue reading

Posted in Uncategorized | Leave a comment

CI & Patent News: 14/12/2010

1) Paragraph IV litigations Cephalon, Inc. Vs Apotex, Inc (Product: may be Armodafinil ) Complaint filed at Delaware District Court on December 14, 2010 2) Meda acquires three OTC products from Glaxo in the US (Business wire); Product information is not disclosed. Glaxo markets totally … Continue reading

Posted in Daily interesting IP news | Leave a comment

CI & Patent News: 11/12/2010

1) Paragraph IV litigation 1) Astellas Vs Nycomed (Tacrolimus ointment 0.1% Protopic) Complaint filed at District of New Jersey on Dec. 7, 2010 Patents in suit: 5,385,907; 5,665,727; View on PriorSmart; This is third complaint filed by Astellas 2) Shionogi Pharma & CIMA Labs … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , , , | Leave a comment

CI & Patent News: 09/12/2010

1) Alnylam Says It Won Europe RNA Patent Dispute (PharmaLive) 2) NovaBay Pharmaceuticals and Galderma Expand Their Agreement to Include Impetigo (Yahoo finance) 3) Orexigen® Therapeutics’ Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity (Yahoo finance) 4) … Continue reading

Posted in Daily interesting IP news | Leave a comment

CI & Patent News: 08/12/2010

1) Paragraph IV Litigations Novartis  v. Aurobindo Pharma (Amlodipine + benazapril) Complaint filed at District of New Jersey on Dec. 3, 2010 Patents in suit: 6162802 (Expires on Dec 19, 2017) View on PriorSmart 2) GSK signs agreement to acquire Nanjing MeiRui Pharmaceuticals in China (press … Continue reading

Posted in Daily interesting IP news | Leave a comment

CI & Patent News: 06/12/2010

1) Paragraph IV litigation Hoffmann-LaRoche Inc. v. Apotex Inc (ibandronate sodium) Complaint filed at District of New Jersey on Dec. 2, 2010 View on PriorSmart Shire LLC, Supernus Pharmaceuticals, Incl et. al. v. IMPAX Laboratories, Inc & Watson (Guanfacine HCl) Complaint filed at District … Continue reading

Posted in Daily interesting IP news | Tagged | Leave a comment

Teva-Enoxaparin-Momenta & Sandoz

On december 02, 2010, Momenta and Sandoz sued Teva for patent infringement of its US FDA pending enoxaparin ANDA. Sanofi Aventis is innovator for enoxaparin and Sandoz has recently received approval of its ANDA. Sandoz has developed enoxaparin ANDA product in alliance with Momenta pharma Momenta … Continue reading

Posted in Patent case | Tagged , , , | Leave a comment

CI & Patents News: 2/12/2010

1) Para IV: Ibandronate tablets: Hoffmann La Roche Vs Watson (View on PriorSmart) Filed at District of New Jersey on Nov. 29, 2010 7,410,957: html | pdf Method of treatment using bisphosphonic acid by Bauss et. al.; USPC #514/108; prosecuted by Johnston; George W. Rocha-Tramaloni; … Continue reading

Posted in Daily interesting IP news | 2 Comments